Skip to main content

Kazimi A J's Form 4 filing

Cumberland Pharmaceuticals Inc (CPIX) ยท filed Nov 5, 2021

Accession no.
0001209191-21-063222
Filed
Nov 5, 2021
Trade date
Oct 1-29, 2021
Filing delay
35 daysLate
Rule 10b5-1 plan
Not on the form (before 2023)

This filing lists 21 non-derivative transactions. Open-market purchases total $856.95. It was filed 35 days after the trade, past the 2-business-day deadline.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Kazimi A JCIK 0001075050Director, Officer (Chairman and CEO), 10% Owner

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Oct 1, 2021Common StockPPurchaseAcquired+15$2.69+$40.355,769,474Direct
Oct 4, 2021Common StockPPurchaseAcquired+15$2.87+$43.055,769,489Direct
Oct 5, 2021Common StockPPurchaseAcquired+15$2.82+$42.35,769,504Direct
Oct 6, 2021Common StockPPurchaseAcquired+15$2.76+$41.45,769,519Direct
Oct 7, 2021Common StockPPurchaseAcquired+15$2.76+$41.45,769,534Direct
Oct 8, 2021Common StockPPurchaseAcquired+15$2.84+$42.65,769,549Direct
Oct 11, 2021Common StockPPurchaseAcquired+15$2.73+$40.955,769,564Direct
Oct 12, 2021Common StockPPurchaseAcquired+15$2.71+$40.655,769,579Direct
Oct 13, 2021Common StockPPurchaseAcquired+15$2.71+$40.655,769,594Direct
Oct 14, 2021Common StockPPurchaseAcquired+15$2.81+$42.155,769,609Direct
Oct 15, 2021Common StockPPurchaseAcquired+15$2.76+$41.45,769,624Direct
Oct 18, 2021Common StockPPurchaseAcquired+15$2.75+$41.255,769,639Direct
Oct 19, 2021Common StockPPurchaseAcquired+15$2.76+$41.45,769,654Direct
Oct 20, 2021Common StockPPurchaseAcquired+15$2.63+$39.455,769,669Direct
Oct 21, 2021Common StockPPurchaseAcquired+15$2.65+$39.755,769,684Direct
Oct 22, 2021Common StockPPurchaseAcquired+15$2.66+$39.95,769,699Direct
Oct 25, 2021Common StockPPurchaseAcquired+15$2.64+$39.65,769,714Direct
Oct 26, 2021Common StockPPurchaseAcquired+15$2.64+$39.65,769,729Direct
Oct 27, 2021Common StockPPurchaseAcquired+15$2.61+$39.155,769,744Direct
Oct 28, 2021Common StockPPurchaseAcquired+15$2.61+$39.155,769,759Direct
Oct 29, 2021Common StockPPurchaseAcquired+15$2.72+$40.85,769,774Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

No transaction price on this filing refers to a footnote.

Read the full filing on SEC EDGAR (opens in a new tab)